Sharepoint Solutions
PRODUCTS
-
The BlisterJet is a fully digital piezo inkjet system. It prints on blank pharmaceutical blisters. The solvent-free, UV-curable inks print sharp graphics and text in one to two colors. The system is available for inline or near-to-line configurations.
-
The most widely trusted solution for clinical trial disclosure management
Managing clinical trial disclosures can be tedious and error-prone, opening the door to noncompliance. TrialScope Disclose provides a better way.
Our centralized platform automates data entry and reporting for Clinicaltrials.gov, CTIS, and more. This reduces manual effort so you can focus on bringing new treatments to patients, not paperwork.
-
Contracting an in-country pharmaceutical clinical depot brings efficiencies to your clinical trial distribution. From its facilities in Montreal, Quebec, Ropack handles most paperwork, permissions, components, warehousing, packaging, distribution, collection, and destruction as a single project.
-
Corning disposable Erlenmeyer flasks are ready to use and ideal for shaker culture applications and storage. All of our disposable Erlenmeyer flasks feature molded in graduations for accuracy, are certified nonpyrogenic, are individually packaged, and come with a vent cap option for continuous gas exchange while preventing leakage.
The showpiece of the Erlenmeyer family is the 5L Erlenmeyer, a vessel designed to aid in the scale-up suspension culture with space efficiency in mind. The 5L Erlenmeyer occupies the same footprint as the 3L Erlenmeyer while offering an additional 2.5L of working volume.
-
Our experienced Regional Site Managers (RSMs) are recapturing the importance of building relationships with clinical sites. Our RSMs can act as a “one-stop shop” for all activities related to a clinical study site.
WHITE PAPERS AND CASE STUDIES
-
Navigating The Translation To Clinic: Future-Proof Your Plasmid Products
Future-proofing products with strategies that reduce risk and timelines for later stages can be resource-intensive but add significant value. Explore the challenges encountered progressing from development to clinic.
-
AqueoUS Vets Named A Manufacturing Partner For A Southern CA Water Treatment Facility
In August 2018, Aqueous Vets was selected over existing industry incumbents to supply the Granular Activated Carbon Systems (GACS) for a Southern California Water Treatment Plant.
-
Decentralized Trials For Duchenne Muscular Dystrophy
Partnering with a global biotech, see how MRN was able to conduct 180+ monthly home visits to sustain trials for rare disease genetic medicine in vulnerable pediatric patients during COVID-19.
-
Are You Leveraging All Of Your Clinical Data?
To develop and execute a successful clinical strategy, trial sponsors must be able to rapidly acquire detailed data insights. Learn how you can better utilize your trial data and achieve greater insights.
-
Regulatory Considerations For Excipients Used In Lipid Nanoparticles
Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.
-
Applying A Platform Approach To Bispecific Antibody Development
Explore how experts were able to adjust a mAb production and purification platform to be applicable for the rapid development and scale up of a BsAb.
-
The Impact Of Artificial Intelligence On CQV
AI is revolutionizing CQV in life sciences by automating documentation, enabling real-time monitoring, and driving predictive quality to boost efficiency and compliance across validation processes.
-
Optimal Syringe Carton Design To Meet Drug Manufacturers' Needs
Learn about the advantages of an optimal packaging design and the resulting benefits of its implementation to the overall process.
-
Reducing Risk And Timelines In Cell Line Development
Accelerate your biologic development by adopting faster, more reliable clone selection methods that reduce time and resources while improving the likelihood of identifying stable, high-producing cell lines.
-
Unveiling The Critical Role of Sleep In Clinical Studies
Explore the critical role of sleep in clinical trials and its impact on health outcomes, emphasizing the need to address sleep disturbances for more effective and reliable research.
-
Design Testing Strategies To Develop A Drug-Device Combination Product
Leveraging the expertise and experience of a trusted partner can reduce risk and accelerate the time to market for drug-device combination products by creating an optimal Validation Master Plan.
-
The Digital Transformation Of A Leading CDMO's Process Development Lab
Discover how a leading CDMO was able to create a data model for its bioreactors, resulting in easily contextualized data, time savings in manual tasks, and the ability to share insights in real time.
NEWS
-
EPA Announces $89M Loan To Enhance Wastewater Management In King County12/18/2024
Today, the U.S. Environmental Protection Agency announced an $89M loan to King County, Washington, to help upgrade several wastewater treatment systems. Provided by the EPA’s Water Infrastructure Finance and Innovation Act (WIFIA) loan program, this funding will support projects that improve the reliability of reclaimed water available for use and enhance the system’s resiliency to future seismic events.
-
Biden-Harris Administration Announces $3B For Lead Pipe Replacement To Advance Safe Drinking Water As Part Of Investing In America Agenda5/2/2024
Today, May 2, the U.S. Environmental Protection Agency announced $3B from President Biden’s Investing in America agenda to help every state and territory identify and replace lead service lines, preventing exposure to lead in drinking water.
-
Biden-Harris Administration Announces $74M WIFIA Loan To Pajaro Valley Water Management Agency In Santa Cruz2/27/2024
Today, the U.S. Environmental Protection Agency (EPA) announced two Water Infrastructure Finance and Innovation Act (WIFIA) loans totaling $74M to the Pajaro Valley Water Management Agency in Santa Cruz County, California.
-
Avance Clinical Expands Specialist CNS, Cardiometabolic, And Rare Diseases CRO Services In Europe With Julius Clinical5/28/2024
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS, cardiometabolic, and rare diseases specialist CRO with extensive site relationships in the region.
-
New Antibiotic Class Effective Against Multidrug-Resistant Bacteria4/1/2024
Scientists at Uppsala University have discovered a new class of antibiotics with potent activity against multi-drug resistant bacteria, and have shown that it cures bloodstream infections in mice. The new antibiotic class is described in an article in the scientific journal PNAS.